Abstract: The present invention provides lipid-based formulations for delivering, e.g., introducing, nucleic acid-lipid particles comprising an interference RNA molecule to a cell, and assays for optimizing the delivery efficiency of such lipid-based formulations.
Type:
Application
Filed:
June 7, 2005
Publication date:
January 12, 2006
Applicant:
Protiva Biotherapeuties, Inc.
Inventors:
Ian MacLachlan, Lorne Palmer, James Heyes